Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Financial Disclosure
The University of Florida Medical School provided all outside activity disclosure data for faculty from forms filed from 2016 through June 2019. Faculty are required to report outside activities that could give rise to an appearance of conflict of interest and get approval for them.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Mark Atkinson
University of Florida, Department: Md Pathology General
Should you be removed from our database? Contact us at [email protected]. Read more below.
Pancreum
This is a relatively new start up whose founders were, years ago, responsible for the development of a (now) widely popular device for diabetes known as the POD. They left that company (Insulet) and started this new venture whose goal is to develop a simple, low cost, pod like device that will not only administer insulin but monitor blood glucose. They seek my involvement in that now, in a second career life, seek to have the new device used in developing (poor) nations. I will advise in that capacity. Until they obtain funding (which they do not have, at present) I will participate in quartley phone calls of ~2 hour duration, each.
On phone, in Gainesville
Filed on June 20, 2018.
Tell us what you know about Mark Atkinson's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Mark Atkinson”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Mark Atkinson | University of Florida | Financial Disclosure | T1D Capital LP | |
| Mark Atkinson | University of Florida | Financial Disclosure | OneVax LLC | |
| Mark Atkinson | University of Florida | Financial Disclosure | Nirmidas Biotech | |
| Mark Atkinson | University of Florida | Financial Disclosure | Merck | |
| Mark Atkinson | University of Florida | Financial Disclosure | Medimmune, Inc | |
| Mark Atkinson | University of Florida | Financial Disclosure | Tenacia | |
| Mark Atkinson | University of Florida | Financial Disclosure | GlaxoSmithKline | |
| Mark Atkinson | University of Florida | Financial Disclosure | Kairos Ventures | |
| Mark Atkinson | University of Florida | Financial Disclosure | IM Therapeutics |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.